David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...
This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...
Trifecta Health and Trifecta Med Spa are excited to announce two strategic cooperations aimed at improving patient access to high-quality obesity treatments. These cooperations will streamline the ...
Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug ...
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.
The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...
Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...
Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label, the FDA ...
Investing.com -- Allurion Technologies Inc. (NYSE:ALUR) stock surged 10.9% in Tuesday’s premarket trading after the weight loss technology company announced significant progress in its FDA approval ...
Alabama Attorney General Steve Marshall says that a Cullman County Circuit Court approved his request for a temporary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results